parenting

Women with multiple sclerosis (MS) who have children experience significantly longer waits before receiving a diagnosis than women without children, according to a new U.S. study. On average, each child was associated with an additional 1.28-year delay in diagnosis. The delay was even longer among women whose symptoms…

When Jill Blackburn’s daughter, Sierra, was diagnosed with pediatric multiple sclerosis (MS) at the age of 15, Blackburn had trouble finding sufficient support and resources. She eventually joined a relevant Facebook group, which she evolved into a nonprofit organization, the Pediatric Multiple Sclerosis Alliance. She now serves as…

“The Longest Shortest Time.” The title of this parenting podcast says it all. How can it feel like your kids will never outgrow a stage, while simultaneously being way bigger than you remember them being just yesterday? Living with a chronic disease like multiple sclerosis (MS) reminds me…

My youngest child is home from college for the summer. She had a fantastic freshman year, or as I tell others, “She’s living her best life.” I missed her this past year in so many ways. She never went through the “bad” teenage years. She actually enjoys spending time with…

Tysabri (natalizumab), an approved treatment for forms of multiple sclerosis (MS), can be safely used during pregnancy or while breastfeeding, a study showed. “The findings of our observational study offer … relevant insight into the safety profile of [Tysabri] therapy not only during pregnancy but also during breastfeeding,”…

On May 10, surrounded by my loved ones, I received my Master of Arts in educational psychology from the University of Texas at Austin. As I heard the words of love and encouragement from my family and friends, I realized just how difficult my educational journey has been because of…

Treatment during pregnancy with the approved multiple sclerosis (MS) medication Copaxone (glatiramer acetate injection) does not appear to increase the risk of birth defects in infants, and its use while breastfeeding is not linked to growth problems in the youngsters, according to follow-up data of mothers and their children…

Sheila Hofmeister and her husband, Rick, stand behind the wheelchair of their son Ben Hofmeister, whose three sons, Sterling, Jule, and Monte, are pictured from left to right. (Photos courtesy of Ben Hofmeister) Day 30 of 31 This is Sheila Hofmeister’s story: Note: Multiple Sclerosis News Today columnist…

Karly Isaacson’s mother, Donna Ball, laces up Karly’s dress for her wedding last summer. (Photos courtesy of Karly Isaacson) Day 24 of 31 This is Karly Isaacson’s story: When I think of empowerment and multiple sclerosis (MS), I think of my mom. I had my first MS…

Sterling Hofmeister is pictured here at 6 months, carried in a backpack by his father Ben Hofmeister. (Photos courtesy of Ben Hofmeister) Day 15 of 31 This is Sterling Hofmeister’s story: Sterling Hofmeister, far right, is pictured with his brothers and father in 2018. My name is Sterling…

TG Therapeutics is conducting two post-marketing studies to determine how safe Briumvi (ublituximab-xiiy) is among people with relapsing forms of multiple sclerosis (MS) who are pregnant or breastfeeding, as well as their babies. The goal is to generate data on the use of Briumvi during pregnancy and lactation…

When I was initially evaluated for multiple sclerosis (MS), I was asked if I had a family history of the disease. To my knowledge, I did not. Once I received my diagnosis, one of the first things that crossed my mind, after recovering from the initial shock…

Taking antibody-based medications for multiple sclerosis (MS) while breastfeeding does not appear to harm a child’s health or development during at least the first three years of life, according to a preliminary study of more than 180 babies. Children breastfed by mothers taking Tysabri (natalizumab), Ocrevus (ocrelizumab),…

Children with multiple sclerosis (MS) who start on high-efficacy therapies experience fewer relapses and reduced MRI disease activity in the following years, compared with those who are treated first with moderate-efficacy therapies, according to a new study. Rates of severe side effects are similar for both groups, but the…

In people with a family history of multiple sclerosis (MS), exclusive breastfeeding in the first months of life may reduce the risk of developing the disease later on, whereas use of cow’s milk or formula may increase MS risk. That’s according to a new study on the potential impact…

Infants breastfed by mothers on Copaxone (glatiramer acetate) for relapsing forms of multiple sclerosis (MS) do not experience more adverse events, hospitalizations, or need more antibiotics for the first 1.5 years than those in the general infant population. That conclusion comes from new analyses of data from COBRA,…

Einstein said that time is relative, and as I age (gracefully, I hope), I’ve found that to be true. For example, I frequently find myself referring to events that occurred a decade or more in the past as happening “just the other day.” In my mind, I’m still…

Women with multiple sclerosis (MS) may have a higher risk of giving birth to premature or smaller babies, but it’s unclear if using MS medications during pregnancy has an effect on the baby’s health, according to a systematic review. The long-term health outcomes of children whose mothers have…

Dr. April Bee’s mother taught her, through words and actions, to embrace people for who they are. (Courtesy of Dr. April Bee) Day 25 of 31 This is Dr. April Bee’s story: Mama was bold and audacious. She cried with me when I cried. She laughed at things I…

MS Australia is funding a study by researchers at Curtin University into how diet might affect multiple sclerosis (MS) onset in children. Led by Eleanor Dunlop, PhD, a dietitian and postdoctoral researcher at the Perth university’s School of Population Health, the study will investigate the influence different types of…

The use of disease-modifying therapies (DMTs) by pregnant women with multiple sclerosis (MS) significantly increased over the last decade or so, and fewer of them are stopping treatment before giving birth, a single-center study in Italy reported. While most patients (95.1%) discontinued a DMT while pregnant between 2005…

Gilenya (fingolimod) and Tysabri (natalizumab) were more effective at lowering relapse rates in children with multiple sclerosis (MS) than interferon-beta, according to a recent meta-analysis. Findings like these can be leveraged for better clinical trial design, the researchers wrote. If used to determine “historical” relapse rates that…

Taking Copaxone (glatiramer acetate), an approved therapy for relapsing forms of multiple sclerosis (MS), while breastfeeding does not appear to be harmful to infants during their first 18 months, according to a real-life study in Germany called COBRA. “In this study, we compared the development of 120 children in total, whose…

There is minimal data available on the safety of most disease-modifying therapies for multiple sclerosis (MS) when used during breastfeeding, a new review indicates. The study “Disease-Modifying Drugs and Breastfeeding in Multiple Sclerosis: A Narrative Literature Review,” was published in Frontiers in Neurology. Disease-modifying therapies, or DMTs,…

Maternal or paternal exposure prior to conception to the multiple sclerosis (MS) therapy Aubagio (teriflunomide) does not seem to increase the risk of adverse pregnancy events, including miscarriage, preterm birth, small newborn size, or malformations, according to the results of a recent Danish study. About…

Photo courtesy of Manuela Lama Day 1 of 31 This is Manuela Lama’s (@manuela.p) story: Caring for someone with multiple sclerosis can be challenging, exhausting, and stressful. As a single mother of a daughter with MS, I have been not only physically tired, but, even more…

The psychological distress of a parent whose child is found to have multiple sclerosis (MS) may directly impact the quality of life of the child. That’s according to a new study that revealed a worse health-related quality of life (HRQoL) in MS children after their diagnosis. These findings support…

The label of Copaxone (glatiramer acetate) — an approved therapy for relapsing forms of multiple sclerosis (MS) — has been updated in Europe to no longer contain a warning against its use during breastfeeding. The label update follows a review by European Union health authorities of non-clinical and clinical evidence submitted…